Figure - PMC

Skip to main content

An official website of the United States government

Here's how you know

Here's how you know

Official websites use .gov
A .gov website belongs to an official government organization in the United States.

Secure .gov websites use HTTPS
A lock ( ) or https:// means you've safely connected to the .gov website. Share sensitive information only on official, secure websites.

View full-text article in PMC

. 2021 Sep 17;12:702072. doi: 10.3389/fgene.2021.702072

Search in PMC
Search in PubMed
View in NLM Catalog
Add to search

Copyright © 2021 Fang, Qu, Wang, Tang, Yan, Ma and Gao.

This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.

PMC Copyright notice

m⁶A score might be used for predicting the response to immunotherapy. (A,B) Violin plots for visualizing IC50 values of (A) cisplatin and (B) gemcitabine in high and low m⁶A score groups. (C) Violin plots of TIDE scores in high and low m⁶A score groups. Comparisons between groups were analyzed with Wilcoxon test. (D) ROC curves for assessing the response to immunotherapy based on m⁶A scores. (E) Validation of TIDE scores in high and low m⁶A score groups in the GSE79668 dataset. **p < 0.01.